The settlement agreement resolves all outstanding patent litigation relating to AUVELITY. “Axsome is proud of its commitment to innovating treatments aimed at improving the lives of the millions ...

The author writes "A recent federal case in New York presents an instructive look at a court’s evaluation of whether an email ...

Axsome Therapeutics (AXSM) announced that it has entered into a settlement agreement with Teva Pharmaceuticals (TEVA) resolving all patent litigation related to Axsome’s AUVELITY product.

On January 8, 2025, the U.S. District Court for the Eastern District of New York held that an employee’s refusal to sign a ...

today announced that it has entered into a settlement agreement with Teva Pharmaceuticals, Inc. (Teva) resolving all patent litigation related to Axsome’s AUVELITY® (dextromethorphan HBr ...

In accordance with the agreement, the parties will terminate all ongoing litigation between Axsome and Teva regarding AUVELITY patents pending in the U.S. District Court for the District of New Jersey ...

Attorney Kale Feldman joins producer/host Coralie Chun Matayoshi to discuss whether insurance companies have a right to sue defendants (e.g. HEI, Kamehameha Schools) in the Maui wildfire ...

Most schools that intend to opt into revenue sharing are proceeding as though the lion's share of the funds will be slated ...

today announced that it has reached a settlement agreement with Bigger Capital LLC, resolving outstanding litigation and further solidifying the Company's financial foundation for future growth.

Subrogation refers to the legal right of an insurance company ... claims against the defendant wrongdoers, the global settlement agreement will collapse, and HEI could go bankrupt.

(RTTNews) - Biopharmaceutical company Axsome Therapeutics, Inc. (AXSM) announced that it has entered into a settlement agreement with Teva Pharmaceuticals, Inc. resolving all patent litigation ...